Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 30:2019:8690546.
doi: 10.1155/2019/8690546. eCollection 2019.

Health Care Professionals' Knowledge, Attitude, and Practice towards Adverse Drug Reaction Reporting and Associated Factors at Selected Public Hospitals in Northeast Ethiopia: A Cross-Sectional Study

Belete Kassa Alemu  1 , Tessema Tsehay Biru  2
Affiliations

Health Care Professionals' Knowledge, Attitude, and Practice towards Adverse Drug Reaction Reporting and Associated Factors at Selected Public Hospitals in Northeast Ethiopia: A Cross-Sectional Study

Belete Kassa Alemu et al. Biomed Res Int. .

Abstract

Background: The role of health care professionals among other stakeholders in early detection, assessment, documentation, and reporting as well as preventing suspected adverse reactions is very crucial to mitigate drug-related problems in health facilities. Previous reports from literatures have indicated that adverse drug reaction reporting is highly linked to the knowledge and attitude of the health care professionals.

Objective: To assess knowledge, attitude, and practice of health care professionals about adverse drug reactions and the associated factors at selected public hospitals in Northeast Ethiopia.

Methods: A hospital-based quantitative cross-sectional study design was employed. A structured self-administered questionnaire was used to collect data on KAP of selected health care providers by the convenience sampling method. Data were entered into Epi info version 3.5.3 and analyzed using SPSS Version 20. Association between dependent and independent variables was found by using bivariate and multivariate logistic regression analysis where p < 0.05 was considered to be statistically significant.

Results: Out of 120 questionnaires distributed, 114 respondents filled and returned, giving a 95% response rate. From total, 49 (43%) were nurses, 26 (22.8%) physicians, 17 (14.9%) pharmacy professionals, 12 (10.5%) health officers, and 10 (8.8%) midwives. About 86 (75.44%) study participants had an inadequate knowledge towards ADR reporting, and half of participants failed to report the adverse drug reactions they encountered. But the majority of participants (84, 73.68%) had a favorable attitude towards ADR reporting. Nurses [AOR = 0.069, 95% CI (0.018-0.275)], health officers [AOR = 0.10, 95% CI (0.015-0.647)], and physicians [AOR = 0.14, 95% CI (0.03-0.64)] were found to be less likely to have adequate knowledge on ADR reporting compared to pharmacy professionals.

Conclusion: Even though the majority of health care professionals had a positive attitude, they had inadequate knowledge and poor practice towards ADR reporting.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Perceived strategies suggested by HCPs to enhance ADR reporting.
Figure 2
Figure 2
Overall knowledge of HCPs about ADR reporting in selected public hospitals, Northeast Ethiopia, May 2019.
Figure 3
Figure 3
Overall attitude of HCPs about ADR reporting in selected public hospitals, Northeast Ethiopia, May 2019.
Figure 4
Figure 4
Overall practice of HCPs on ADR reporting in selected public hospitals, Northeast Ethiopia, May 2019. Out of 114 HCPs, only 17 (14.91%) participants had documented and reported encountered ADRs. However, 97 (85.09%) participants did not encounter, document, and/or report ADRs.
See this image and copyright information in PMC

References

    1. World Health Organization. Policy Perspectives on Medicines Pharmacovigilance: Ensuring the Safe Use of Medicines. Geneva, Switzerland: WHO; 2004.
    1. (WHO/UMC) DKS. Guideline for Adverse Drug Events Monitoring (Pharmacovigilance) 3rd Edition. Addis Ababa, Ethiopia: Food, Medicine and Healthcare Administration and Control Authority of Ethiopia; 2014.
    1. World Health Organization. Safety Monitoring of Medicinal Products: Guidelines for Setting up and Running a Pharmacovigilance Centre. Geneva, Switzerland: World Health Organization; 2000.
    1. Bouvy J. C., De Bruin M. L., Koopmanschap M. A. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Safety. 2015;38(5):437–453. doi: 10.1007/s40264-015-0281-0. - DOI - PMC - PubMed
    1. Lundkvist J., Jonsson B. Pharmacoeconomics of adverse drug reactions. Fundamental and Clinical Pharmacology. 2004;18(3):275–280. doi: 10.1111/j.1472-8206.2004.00239.x. - DOI - PubMed